Novartis, Incyte Settle Drug Royalty Fight On Eve Of Trial

A Manhattan federal judge put off trial on Monday in a five-year quest by Novartis to recover what it says are $500 million in missing royalties from its agreement to commercialize...

Already a subscriber? Click here to view full article